Effector T cells migrate to the tumor site, where tumor cells induce an increase in MHC II expression on these T cells 

Tumor cells secrete the same serine proteases as neutrophils to evade immune detection

By activating T effector cells to target tumor cells

Decrease in MHC class I levels

Long-lived plasma cells are recruited to the tumor site to coat tumor cells with antibodies, preventing immune detection